Target intelligence / Profile preview

Immunoglobulin lambda variable 11-55 (IGLV11-55)

Target
IGLV11-55
Molecular classification
Immunoglobulin domain-containing protein, Variable region segment of immunoglobulin light chain, "Other" (not an active receptor, enzyme, transporter, or ion channel)
01

Overview

Immunoglobulin lambda variable 11-55 (IGLV11-55) is a variable region gene segment of the human immunoglobulin lambda light chain locus, located on chromosome 22q11.2[3]. It is classified as a probable "non-functional open reading frame" (ORF), meaning that it generally cannot participate in the synthesis of a productive immunoglobulin light chain due to recombination defects, splicing errors, or conserved amino acid changes[1][3]. Immunoglobulins normally serve as receptors on B lymphocytes or as secreted antibodies in humoral immunity, but non-functional variable regions such as IGLV11-55 do not contribute to these processes[1][3]. The locus itself contains dozens of variable region genes, pseudogenes, and orphons that together expand immunoglobulin diversity but only a subset are functional[3]. IGLV11-55 is catalogued in immunogenetics databases due to gene mapping efforts, but has no evidence of direct biological or therapeutic relevance.

Other names
IGLV11-55Probable non-functional immunoglobulin lambda variable 11-55IGLV1155V4-6LVK55
02

Mechanism of action

Null; no mechanism established for drug targeting

03

Biological functions

None ascribed; predicted not to participate in normal biological functions due to non-functionalityIf functional, similar proteins typically participate in the immune response and antigen recognition—but this segment is non-functional
04

Disease associations

Null (no direct role established)A genetic association(weak) with Autism Spectrum Disorder has been noted, likely based on gene proximity or homology rather than any proven mechanism
05

Safety considerations

Null; not relevant for therapeutic targeting due to non-functionality
06

Interacting drugs

None; as a non-functional gene segment, there are no known drugs that interact specifically with IGLV11-55
07

Biomarkers

Null; this is not used as a biomarker for patient selection or efficacy monitoring

Beyond the preview

Go deeper on Immunoglobulin lambda variable 11-55 (IGLV11-55).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin lambda variable 11-55 (IGLV11-55).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call